ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatm…
Biotechnology
US, South San Francisco [HQ]
Value per Employee (VpE) · Surveys · Talents
Employees Analysis
Value per Employee (VpE) · Surveys · Talents
Employee Surveys
Employees Asked: -No survey available at the moment.